| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Related Subjects: Type 1 DM | Type 2 DM | Diabetes in Pregnancy | HbA1c | Diabetic Ketoacidosis (DKA) Adults | Hyperglycaemic Hyperosmolar State (HHS) | Diabetic Nephropathy | Diabetic Retinopathy | Diabetic Neuropathy | Diabetic Amyotrophy | Maturity Onset Diabetes of the Young (MODY) | Diabetes: Complications |
| Range | UK (mmol/L) | US (mg/dL) |
|---|---|---|
| ✅ Normal (fasting) | 4.0 – 5.9 | 72 – 106 |
| ✅ Normal (post-meal) | 4.0 – 7.8 | 72 – 140 |
| ⚠️ Pre-diabetes (fasting) | 6.0 – 6.9 | 108 – 124 |
| 🩸 Diabetes (fasting) | ≥ 7.0 | ≥ 126 |
| ⬇️ Hypoglycaemia | < 4.0 | < 72 |
| 📊 Random diabetes dx | ≥ 11.1 | ≥ 200 |
| ⚠️ High hyperglycaemia | 20 | 360 |
| 🚨 Severe hyperglycaemia | 30 | 540 |
💡 Exam Tip: Quote “4–11 mmol/L” as the safe inpatient target, but “4–8 mmol/L” post-MI for tighter control. One small clinical caveat: VRII tables vary a lot between trusts, especially the paired substrate fluid, potassium rules, and escalation thresholds, so keeping “check local guideline” in the heading is exactly right.
Preparation: 50 units soluble insulin in 49.5 mL 0.9% NaCl via syringe pump. Run alongside 5% dextrose + 40 mmol KCl at 30 mL/hr (unless hyperkalaemic).
| Capillary Blood Glucose | mg/dL | VRII Rate | Action |
|---|---|---|---|
| <4.0 mmol/L | <72 | 🚫 Stop infusion | Treat hypoglycaemia urgently. |
| 4.1–6.0 mmol/L | 74–108 | 1 mL/hr | Continue monitoring. |
| 6.1–8.0 mmol/L | 110–144 | 2 mL/hr | Continue monitoring. |
| 8.1–10.0 mmol/L | 146–180 | 3 mL/hr | Continue monitoring. |
| 10.1–12.0 mmol/L | 182–216 | 4 mL/hr | Continue monitoring. |
| 12.1–14.0 mmol/L | 218–252 | 5 mL/hr | Continue monitoring. |
| >14.1 mmol/L | >254 | 6 mL/hr | Use for 2 hours; if glucose remains elevated, check IV line/cannula and call a doctor. |